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Abstract: The purpose of this study was to evaluate the frequency of multifocal osteonecrosis in patients with sickle cell 
disease. Between 1980 and 1989, 200 patients with sickle cell disease were treated in our institution for osteonecrosis. The 
patient population consisted of 102 males and 88 females with a mean age of twenty-six years at the time of presentation 
(range, eighteen to thirty-five years) and was followed until the year 2005. This cohort of patients was follow-up during 
average 15 years (until the year 2005). Multifocal osteonecrosis was defined as a disease of 3 or more anatomic sites. At 
the time of presentation, 49 patients were identified as having multifocal osteonecrosis. At the most recent follow-up, 87 
patients had multifocal osteonecrosis. So at the last follow up among these eighty-seven patients, the occurrence of 
osteonecrosis was 158 lesions of the proximal femur associated with 151 proximal humerus osteonecroses, thirty-three 
lateral femoral condyle osteonecroses, twenty-eight distal femoral metaphysis osteonecroses, twenty-seven medial 
femoral condyle osteonecroses, twenty-three tibial plateau osteonecroses, twenty-one upper tibial metaphysis 
osteonecroses and forteen ankle osteonecroses. The total number of osteonecrosis was 455 in these 87 patients. The 
epiphyseal lesions were more frequent than the metadiaphyseal lesions excepted in the proximal tibia (Table 3). In 
conclusion, in patients with sickle cell disease, the risk of multifocal osteonecrosis is very high. In patients with hip 
osteonecrosis, the other joints should be evaluated with radiograph and MRI if the joint is symptomatic. In patients with 
osteonecrosis of the knee, shoulder or ankle, the patients’ hip should be evaluated by radiographs or MRI, regardless of 
whether the hip is symptomatic. 
INTRODUCTION 
  Sickle cell disease is an important cause of osteonecrosis 
affecting persons in Africa, in the United States of America, 
in the Indian Subcontinent, in the Persian Gulf and in the 
Mediterranean countries. Osteonecrosis affects the hip most 
commonly [1, 2] but may also affects other sites [3] 
including the knee, shoulder, ankle, spine and other joints. 
When the disease extents to several joints, the effects on the 
patients are magnified. There have been only a few case 
reports concerning multifocal osteonecrosis [4, 5] and these 
studies have included a very small number of patients with 
sickle cell disease. However in the experience of the authors, 
sickle cell disease is a frequent comorbidity associated with 
multifocal osteonecrosis. The purpose of this study was to 
review the incidence of multifocal osteonecrosis in this 
disease, the distribution of the joints concerned by multifocal 
osteonecrosis and the clinical consequences in the long term 
(average fifteen years of follow up) of multifocal 
osteonecrosis in these patients with sickle cell disease. 
  To be considered as a multifocal osteonecrosis an 
involvement of three separates sites was necessary. For 
example a patient with osteonecrosis of one hip, one knee,  
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and one shoulder would meet the criteria; a patient with three 
osteonecroses but not three separate sites involved would not 
be considered as multifocal osteonecrosis (example two hips 
and one knee). 
  200 patients homozygous for hemoglobin S (SS 
genotype) but also with the double heterozygous hemoglo-
binopathies (hemoglobin SC genotype and hemoglobin 
SBeta thalassemia) were included in the study. A diagnosis 
based on a hemoglobin analysis was done at our hospital for 
each patient. One thousand and six hundred joints (400 hips, 
knees, shoulders and ankles) were studied in these 200 adult 
patients with sickle cell disease. These 200 patients were 
initially evaluated between 1980 and 1989 and were 
followed every year until year 2005 for a minimum of ten 
years and a mean of fifteen years (maximum twenty years). 
MATERIAL AND METHODS 
  Actually, more than 1500 patients are treated at our 
institution for sickle cell disease. Among this population of 
patients homozygous for hemoglobin S (SS genotype) and 
also those with the double heterozygous hemoglobinopathies 
(hemoglobin SC genotype and hemoglobin S thalassemia) 
200 were included in the study and initially evaluated at the 
time of presentation between 1980 and 1989. The patient 
population consisted of 102 males and 88 females with a 
mean age of twenty-six years at the time of presentation 
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the year 2005. These patients were treated for at least one 
osteonecrosis site. 
  MRI of hips, shoulders, knees, ankles were obtained at 
the entry of the study for all the patients. Patients were 
followed prospectively every year with a radiograph if a 
joint became symptomatic. In absence of evidence of 
osteonecrosis on radiographs of a symptomatic joint, patients 
had an MRI performed. When osteonecrosis was present on 
a joint, the patients had an MRI performed on the 
contralateral joint in absence of radiological evidence of 
osteonecrosis as the contralateral side. The average duration 
of follow-up after inclusion of the patient in the study was 
fifteen years (range ten to twenty). 
  According to the number of MRI performed in this study, 
MRI examinations were limited and performed as screening 
techniques in many joints of these patients. This limited 
examination consisted of T1 weighed images with the 
following parameters: 450-600/10-15 (repetition time msec 
echo time msec); 5 mm thickness, 2 mm intersection gap, 38 
cm field of view, 256 x 256 matrix. In case of osteonecrosis, 
the full examination consisted of additional imaging 
sequences: fast spin echo T2 weighed images with fat 
suppression. 
  The diagnosis of osteonecrosis was done on MRI or 
radiographs. Radiological signs of osteonecrosis in epiphysis 
were sclerotic or cystic changes, crescent line, and collapse. 
In the metadiaphyseal area, demarcating sclerosis was 
considered as a radiologic sign of infarct. Because fatty 
marrow or mixed marrow can be found in the epiphysis of 
patients with sickle cell disease the diagnosis on MR 
imaging was only based on bandlike abnormal signals 
[bandlike hypointense zones on T1 weighted images and 
matching hyperintense zones on short tau inversion (STIR 
images)]. 
  Sites of osteonecrosis were found in the proximal 
femoral epiphysis, in the proximal humeral epiphysis, in the 
distal femoral epiphysis, in the proximal tibial epiphysis, in 
the distal tibial epiphysis and in the talus. In the knee joint 
each femoral condyle and tibial plateau was considered as a 
different site of osteonecrosis. The means for example that 
one knee could have four epiphyseal osteonecroses sites but 
was considered as only one anatomical site. 
  Osteonecrosis was found in two areas: epiphyseal areas 
in contact or not with cartilage and meta diaphyseal areas not 
in contact with endosteum. This means that one knee could 
have two metadiaphyseal osteonecroses and four epiphyseal 
osteonecroses. 
RESULTS 
1. Prevalence of Multifocal Osteonecrosis 
1.1. At Presentation 
  Of the 200 patients, forty-one (20 per cent) were found to 
have multifocal osteonecrosis at study entry. These forty-one 
patients identified as having multifocal osteonecrosis at 
presentation were associated at twenty other patients with 
osteonecrosis in only one or two separate sites. So multifocal 
osteonecrosis represented 67 per cent of patients with 
osteonecrosis at presentation (forty-one among sixty-one). 
  The sixty-one patients with at least one site osteonecrosis 
had disease of the hip at presentation: forty-two who had 
disease of the hip were homozygous for hemoglobin S, 
fourteen had hemoglobin S/hemoglobin C, and five had 
hemoglobin S/B thalassemia. 
  Because 130 of 200 patients in the over-all group were 
homozygous for hemoglobin S, the prevalence of disease of 
the hip in this group at entry of the study was forty-two of 
130 (32 per cent), fourteen of fifty-five (26 per cent) in the 
patients who had hemoglobin S/ hemoglobin C and five of 
fifteen (33 per cent) in the patients with hemoglobin S/B 
thalassemia. 
  The prevalence of multifocal osteonecrosis in these 
patients was respectively for the different hemoglobin 
disease 22 per cent (twenty-eight of 130), 16 per cent (nine 
of fifty-five) and 26 per cent (four of fifteen) at entry of the 
study. 
  One hundred and forty-nine bony lesions were identified 
at presentation among the forty-one patients with multifocal 
osteonecrosis (average 3.6 osteonecrosis per patient). All the 
patients had hip involvement. Other sites involved included 
the shoulder in thirty-seven patients, the knee in eleven 
patients, and the ankle in three patients. Bilaterality (as 
confirmed by radiographs or MRI) was common including 
70 per cent of the hips, 62 per cent of the shoulders, and 45 
per cent of the knees (Table 1). 
1.2. At the Most Recent Follow-Up 
  Of the 200 patients followed for an average of fifteen 
years (minimum ten years, maximum twenty years), eighty-
seven patients had multifocal osteonecrosis at the last follow 
up. All the twenty patients that had osteonecrosis at one or 
two sites at presentation had a multifocal osteonecrosis at the 
most recent follow-up. Twenty-six other patients developed 
multifocal osteonecrosis during the period study. The time 
between diagnosis on the first site and diagnosis of 
Table 1.  Osteonecrosis Involvement at Presentation (Epiphyseal and Metadiaphyseal Lesions) 
 
  Total Number of Osteonecrosis Percentage 
of Sites with Osteonecrosis n, (%) 
Number of Patients with 
Bilateral Lesions n, (%) 
Total Number of 
Patients n, (%) 
Hip  70 (47%)  29 (70%)  41 (100%) 
Shoulder  60 (40%)  23 (62%)  37 (90%) 
Knee  14 (9%)  5 (45%)  11 (27%) 
Ankle  5 (3%)  1 (33%)  3 (7%) 
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osteonecrosis on the second site was within two years for 50 
per cent of the patients; and 25 per cent of the patient 
developed avascular necrosis in the third site within four 
years after the diagnosis at the second site. These eighty-
seven patients identified as having multifocal osteonecrosis 
at the most recent follow up were associated with forty-nine 
other patients with osteonecrosis in only one or two separate 
sites. So multifocal osteonecrosis represented 64 per cent of 
the patients with osteonecrosis at most recent follow up 
(eighty-seven among 136 patients). 
  Among the eighty-seven patients with 158 osteonecroses 
at the proximal part of the femur at the most recent follow-
up, the most common site besides the hip was the proximal 
humerus (eighty-one patients, i.e. 93 per cent), followed by 
the lateral femoral condyle (twenty-five patients, i.e. 29 per 
cent), the distal femoral metaphysis (twenty-one patients, i.e. 
24 per cent), the medial femoral condyle (nineteen patients, 
i.e. 21 per cent), the upper tibial metaphysis (sixteen 
patients, i.e. 18 per cent), and others (Table 2). 
  So at the last follow up (mean 15 years, rage 10 to 20 
years) among these eighty-seven patients, the occurrence of 
osteonecrosis was 158 lesions of the proximal femur 
associated with 151 proximal humerus osteonecroses, thirty-
three lateral femoral condyle osteonecroses, twenty-eight 
distal femoral metaphysis osteonecroses, twenty-seven 
medial femoral condyle osteonecroses, twenty-three tibial 
plateau osteonecroses, twenty-one upper tibial metaphysis 
osteonecroses and forteen ankle osteonecroses. The total 
number of osteonecrosis was 455 in these 87 patients. The 
epiphyseal lesions were more frequent than the 
metadiaphyseal lesions excepted in the proximal tibia (Table 
3). 
2. Incidence of Multifocal Osteonecrosis in the 
Population of this Series 
  At the time of presentation forty-one patients had the 
diagnosis of multifocal osteonecrosis. At the last follow-up 
eighty-seven patients had multifocal osteonecrosis. So of the 
200 patients followed for average 3000 patients-years, forty-
six (23 per cent) had developed multifocal osteonecrosis 
during the period study (1.5 case per 100 patients-year). 
Multifocal osteonecrosis was greatest in the groups with the 
SS genotype (43 per cent, i.e. 37 among eighty-seven) 
followed by those with the hemoglobin SC genotype (38 per 
cent, i.e. 33 among eighty-seven) and patients with the S
+ 
thalassemia genotype (19 per cent, i.e. 17 among eighty-
seven). Because the age distribution of patients differed by 
genotype, age calculated prevalence rate of multifocal 
osteonecrosis were calculated. Pair wise tests of the 
incidence of multifocal osteonecrosis according to the 
genotype revealed that the age-adjusted rates in patients with 
the hemoglobin SS genotype differed from that in patients 
with the hemoglobin SC genotype (p < 0.01). To determine 
whether there was an age specific difference in the incidence 
of multifocal osteonecrosis according to genotype, we 
studied two age groups of interest: patients who were 
between eighteen and thirty years old and these who were 
thirty years old or older. We found that in the older age 
group the incidence of multifocal osteonecrosis (2.8 cases 
per 100 patients-years) was highest among patients with the 
SC genotype. The incidence of multifocal osteonecrosis was 
higher among patients with the S.S. genotype in the younger 
age group (3.6 cases per 100 patients-years). 
  Hip symptoms (with or without multiple joint pain) was 
the most common presentation (thirty-six patients, 87 per 
cent). The shoulder was the only presenting symptomatic 
joint in three patients and the knee the only presenting 
symptomatic joint in two patients. Of the fifty-five joints or 
bone sites in which symptoms initially presented, there was 
forty-five hips (81 per cent of presenting joints), eight 
shoulders (15 per cent of presenting joints), two knees, (47 
per cent). Almost 35 per cent of the hips (twenty-five hips), 
86 per cent of the shoulders (fifty-two shoulders) and 85 per 
cent of the knees (twelve knees) in which osteonecrosis was 
present at presentation had no pain or limitation of motion at 
the time of diagnosis. However, all these joints or bone sites 
became painful later and all the joints involved had 
limitation of motion at the most recent follow up. 
DISCUSSION 
  Previous reports concerning multifocal osteonecrosis 
have been limited to case reports or to osteonecrosis 
associated with other risk factors. In our study with sickle 
cell disease we found mean 5.2 sites involved by 
osteonecrosis at the most recent follow-up. The hips were 
involved in all the patients with multifocal osteonecrosis and 
there was a bilateral predominance of all sites. 
  Multifocal disease was found to occur in at least 64 per 
cent of patients as having at least one osteonecrosis. The 
high incidence of osteonecrosis is this series was related to 
the routine use of MRI. There is a risk of underestimation of 
patients with multifocal osteonecrosis since patients may 
have silent lesions not identified in absence of radiographs or 
MRI. This is especially true in sickle cell disease because all 
the osteonecrosis do not occur at the same time and all joints 
do not become symptomatic at the same time. In this series 
Table 2.  Osteonecrosis Involvement at the Last Follow-Up (Epiphyseal and Metadiaphyseal Lesions) 
 
  Total Number of Osteonecrosis Percentage 
of Sites with Osteonecrosis n, (%) 
Number of Patients with 
Bilateral Lesions n, (%) 
Total Number of 
Patients n, (%) 
Hip  158 (35%)  75 (86%)  87 (100%) 
Shoulder  151 (33%)  71 (88%)  81 (93%) 
Knee  132 (29%)  18 (60%)  30 (34%) 
Ankle  14 (3%)  4 (66%)  6 (7%) 
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of 136 patients with at least one osteonecrosis, 60 per cent of 
the patients with osteonecrosis of the hip had multifocal 
osteonecrosis, but 90 per cent of the patients with 
osteonecrosis of the shoulder and 95 per cent of the patients 
with osteonecrosis of the knee had multifocal osteonecrosis 
at the most recent follow-up. This study emphasizes the need 
to screen other joints in patients with osteonecrosis of the 
knee, shoulder because the risk of multifocal osteonecrosis 
in these patients. If a patient complains of pain in other joints 
and if plain radiographs appear normal, MRI is indicated to 
assess osteonecrosis. 
  The authors acknowledge that some areas of 
osteonecrosis may have been missed. Even if hips, shoulders 
and ankles of the patients were evaluated with MRI, other 
asymtomatic joints may not have evaluated and therefore 
unidentified lesions in other sites may be present. 
  Total body scintigraphic bone scans may be an effective 
mean of screening for multifocal osteonecrosis in other 
etiologies. However in sickle cell disease scintigraphic bone 
scans may not be the best diagnostic modality in these 
patients because the hematological disease. Previous reports 
[6-8] have shown increased isotope uptake in peripheral 
extremities, consistent with marrow expansion in all patients 
with sickle cell disease who were examined by using Tc-
99m sulfur colloid. The areas of marrow infarction could not 
be differentiated. 
  With the possible exception of patients with uncommon 
genotype, we can consider that this sample of 200 patients is 
representative of the population of patients with sickle cell 
disease. We found in this study a very high incidence of 
osteonecrosis in sickle cell disease. This may be explained 
by the age of our patients, (particularly with an increase of 
the rate of osteonecrosis in older patients with the 
hemoglobin SC genotype) and by the fact that our patients 
had MRI performed on many joints. This study revealed also 
that patients with sickle cell disease are at highest risk for 
multifocal osteonecrosis. Because about 50 per cent of the 
patients developed avascular necrosis at the second site 
within two years after diagnosis of avascular necrosis at the 
first site and because 25 per cent of the patients developed 
avascular necrosis at the third site within four years after the 
diagnosis at the second site, it may be necessary to screen the 
patients at six months or one year intervals. Because 
avascular necrosis was found to occur as frequently in the 
humeral heads as in the hip at the most recent follow-up, the 
shoulders should be imaged also frequently. 
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Table 3.  Repartition Between Epiphyseal and Metadiaphyseal Ostéonécroses at the Last Follow-Up 
 
  Epiphyseal Osteonecrosis n, (%)  Metadiaphyseal Osteonecrosis n, (%) 
Proximal femur  158 lesions  136 (86%)  22 (14 %) 
Proximal humerus  151 lesions  133 (88%)  18 (12%) 
Distal femur   88 lesions  0 (68%)  28 (32%) 
Proximal tibia   44 lesions  23 (52%)  21 (48%) 
Distal tibial and talus  14 lesions  9 (64%)  5 (36%) 